Cellbricks Therapeutics
Germany, Berlin
About Cellbricks Therapeutics
Cellbricks Therapeutics is a Berlin-based regenerative medicine company spun out of the Technical University of Berlin. It develops light-based 3D bioprinting and AI-driven tissue engineering to produce scalable, immune-compatible, vascularized, patient-specific soft tissue implants and biofabricated tissue therapeutics for indications such as adipose tissue repair, liver patches and breast reconstruction. Its platform combines proprietary DLP light-based bioprinting, custom biomaterials, synthetic biology and AI-driven process control to enable high cell viability, multi-material printing and GMP-aligned manufacturing. Founded in 2016, the company focuses on advancing preclinical programs toward clinical studies.
Latest Funding
SeedAnnounced 2026-03-25
Buying Signals
Where the capital is going, and whether it's already started moving.
Spend Intent
2 signals · where the capital is going
Advancing lead adipose tissue implant program toward clinical trials
globenewswire.com
+1 more capital deployment signal · confidence ratings · source articles
Sign up freeSelling to Cellbricks Therapeutics? You're in the right place.
Knowing they raised is the start. The edge is what's attached to Cellbricks Therapeutics.
Spend intent
Where this round will be spent.
Hiring signals
Which departments are growing.
Verified contacts
Who actually decides.
No credit card. Five minutes, no approvals.
Ask AI
What is the unique value proposition of Cellbricks Therapeutics, and who are their main competitors?
Sign up free to ask AI about Cellbricks Therapeutics
Our AI has read their website, news, and funding history. 25 credits included with every free account.
Sign up free: 25 credits includedAuto-matched to your ICP
Every company, scored against your profile. Automatically.
Industry
High
Size
Mid
Stage
High
Match score blends industry, company size, growth stage, tech stack, and geography. The moment you set your ICP, every company in our database gets scored.
Investors
Silicon Roundabout Ventures
Lead investor · Seed
2 funding rounds total
Funding History
Full accessTech Stack
HTTP/3
Complianz
Litespeed Cache
Key Highlights
AI InsightsPreclinical: bioprinted adipose tissue fully integrated in mice after 7 weeks with rapid vascularization and no fibrosis or rejection.
AI reads their website, press releases, and funding context to surface what makes them unique - so you tailor your pitch before the first call.
Try it free →Generates a personalized cold email based on their funding round, capital deployment signals, and company context. Ready to send in under 10 seconds.
Try it free →Short, personalized connection request crafted around their recent funding and what your product can help them achieve with it.
Try it free →Maps their competitive landscape with AI - invaluable context before your first call and for positioning your pitch against their alternatives.
Try it free →Extracts capital deployment signals from their funding news - reach out knowing exactly where they're investing and why your product fits.
Try it free →Similar Companies
Discover companies similar to Cellbricks Therapeutics
Selling to Cellbricks Therapeutics? You're in the right place.
Knowing they raised is the start. Our difference is what comes attached to Cellbricks Therapeutics.
Spend Intent
Where this round will be spent.
Hiring Signals
Which departments are growing.
Verified Contacts
Who actually decides.
No credit card. Five minutes, no approvals.
Free weekly newsletter on startup funding.
20 rounds, ranked by amount. Industry and stage breakdowns. A short market note. One email, free, no noise. 2,000+ subscribers.
No spam, ever. Unsubscribe with one click.